Professor Glenn A. Okun
The Rabid Capitalist: The Big Point is a brief summary of a detailed note available to paid subscribers.
Oaktree Specialty Lending (OCSL): Keefe Bruyette downgraded the stock to market perform from outperform, reducing its price target to $19 from $22. Quarterly credit issues accounted for the downgrade. Investors will watch and wait for OCSL to demonstrate its credit quality in order for stock performance to improve.
Subscribe to discover how to profit from this news.
Complete content is available for a $15 monthly subscription. Click here to subscribe:
The Rabid Capitalist 
Leave a comment